http://rdf.ncbi.nlm.nih.gov/pubchem/reference/29526710

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 1566
issn 0007-0920
1532-1827
issueIdentifier 11
pageRange 1560-1566
publicationName British Journal of Cancer
startingPage 1560
bibliographicCitation Pallis AG, Voutsina A, Kalikaki A, Souglakos J, Briasoulis E, Murray S, Koutsopoulos A, Tripaki M, Stathopoulos E, Mavroudis D, Georgoulias V. ‘Classical’ but not ‘other’ mutations of EGFR kinase domain are associated with clinical outcome in gefitinib-treated patients with non-small cell lung cancer. British Journal of Cancer. 2007 Nov 13;97(11):1560–6. doi: 10.1038/sj.bjc.6604068.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_405dfc9a88899ff47c2eb1a59b047ae3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9dffc8b51fbb936b6a0d32a9b42b41d6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_842ca400f8532f6cacd31b8c20f7bdee
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_80ba68d6f77e7fb5e54f408e26b54c67
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cf1cda3dc65fcdf7775684cb21af97ca
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d714685732262694db78c03ec5e41f93
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f9e27d644c6f4b5f3debb57368e8f342
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f29dadef4de46e7605242be9c3e2d6ae
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f99e757daab7f51dd8b468e9b2f27449
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_30c29decce711bde5e273cfb06c034ff
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6ddeaeef25907ac6ae6bf95a71ff5719
date 2007-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/18000506
https://doi.org/10.1038/sj.bjc.6604068
https://pubmed.ncbi.nlm.nih.gov/PMC2360265
isPartOf https://portal.issn.org/resource/ISSN/1532-1827
https://portal.issn.org/resource/ISSN/0007-0920
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1765
language English
source https://scigraph.springernature.com/
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title ‘Classical’ but not ‘other’ mutations of EGFR kinase domain are associated with clinical outcome in gefitinib-treated patients with non-small cell lung cancer
discusses http://id.nlm.nih.gov/mesh/M0593322
http://id.nlm.nih.gov/mesh/M0444984
http://id.nlm.nih.gov/mesh/M0018336
http://id.nlm.nih.gov/mesh/M0457532
http://id.nlm.nih.gov/mesh/M0001483
hasSubjectTerm http://purl.org/au-research/vocabulary/anzsrc-for/2008/11
http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID712
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fddb60309b0ee16f8cd57b4b90c99e89
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8a65ae2c3e323ad41efdc6b71be9712d
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123631
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68245

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1956
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129683629
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128865459
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129221764
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127377427
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128368393

Total number of triples: 52.